Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAM and PEC I Block for Pain Control in Breast Surgery
NCT02647385Active, not recruiting
- Sponsor
- Hospital Sírio-Libanês
- Start
- Dec 2015
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of lidocaine in breast cancer (2 arms), sponsored by Hospital Sírio-Libanês. Primary endpoint: Patient's Pain assessment at 24 hours. Started Dec 2015; status: active, not recruiting.
02
Drugs
lidocaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02647385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647385.